Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Rush Multiple Sclerosis Center is a premier clinical and research facility located within the Rush University System for Health in Chicago. Recognized as a Center for Comprehensive MS Care by the National Multiple Sclerosis Society, it provides multidisciplinary treatment for patients with multiple sclerosis and related demyelinating disorders. The center integrates advanced clinical care with a robust research program, participating in numerous Phase 1 through Phase 4 clinical trials for novel disease-modifying therapies. Its expertise spans neuroimaging, neuro-immunology, and rehabilitative medicine, aiming to improve long-term outcomes and quality of life for patients. As part of an academic medical center, it also serves as a major training ground for the next generation of MS specialists.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rush Multiple Sclerosis Center.